Table 4.
Adverse events according to randomized treatment arm
| Lower DNa | Higher DNa | |
|---|---|---|
| Adverse event | (n = 69) | (n = 70) |
| (No. of participants) | (No. of events) | |
| Hypotension (SBP <90 mmHg) | 9 (9) | 6 (7) |
| Hypertension (SBP >180 mmHg) | 3 (3) | 7 (7) |
| Chest pain/MI | 4 (4) | 1 (1) |
| Tachycardia | 1 (1) | 1 (1) |
| Diaphoresis | 1 (1) | 1 (1) |
| Dyspnea | 0 (0) | 1 (1) |
| Cough | 2 (3) | 0 (0) |
| Nausea | 3 (3) | 3 (4) |
| Abdo/back pain | 3 (3) | 3 (3) |
| Bloating | 1 (1) | 0 (0) |
| Diarrhea | 0 (0) | 1 (1) |
| Perirectal abscess | 1 (1) | 0 (0) |
| Cramping | 7 (10) | 6 (8) |
| Altered mental status | 2 (2) | 2 (2) |
| Headache | 0 (0) | 2 (3) |
| Dizziness | 1 (1) | 0 (0) |
| Anxiety | 2 (2) | 0 (0) |
| Restless legs | 1 (1) | 0 (0) |
| Trembling | 0 (0) | 1 (1) |
| Itch | 1 (1) | 1 (1) |
| Access dysfunction | 2 (2) | 2 (3) |
| Other pain | 5 (8) | 4 (6) |
| Eye pain | 0 (0) | 1 (1) |
MI, myocardial infarction.